乙肝患者-话题@MedSci - 梅斯（MedSci）

#乙肝患者#

55篇内容 | 1936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1671771, encodeId=a64a16e177147, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=BMC Med：乙肝患者更易肾损伤, objectType=article, longId=144369, objectId=793c1443690b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=793c1443690b, replyNumber=0, likeNumber=62, createdTime=2018-09-21, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=793c1443690b, moduleTitle=BMC Med：乙肝患者更易肾损伤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=793c1443690b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671766, encodeId=0fcc16e176630, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：抗血小板治疗会降低慢性乙肝患者HCC风险吗？, objectType=article, longId=120963, objectId=773d12096392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773d12096392, replyNumber=0, likeNumber=104, createdTime=2018-01-03, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773d12096392, moduleTitle=Hepatology：抗血小板治疗会降低慢性乙肝患者HCC风险吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=773d12096392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671763, encodeId=06ef16e176379, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？, objectType=article, longId=115879, objectId=992f1158e9e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=992f1158e9e6, replyNumber=0, likeNumber=74, createdTime=2018-06-04, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=992f1158e9e6, moduleTitle=Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=992f1158e9e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671765, encodeId=a63716e1765d1, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=乙肝患者服药后身高缩了8厘米，法院判决医院承担30%责任, objectType=article, longId=120904, objectId=44c31209042e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c31209042e, replyNumber=0, likeNumber=73, createdTime=2018-11-02, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c31209042e, moduleTitle=乙肝患者服药后身高缩了8厘米，法院判决医院承担30%责任, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=44c31209042e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671758, encodeId=bda916e175873, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险, objectType=article, longId=103648, objectId=172710364852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172710364852, replyNumber=0, likeNumber=79, createdTime=2018-02-03, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172710364852, moduleTitle=Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=172710364852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671764, encodeId=520016e176433, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果, objectType=article, longId=119956, objectId=3b4611995631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b4611995631, replyNumber=0, likeNumber=102, createdTime=2018-07-31, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b4611995631, moduleTitle=Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b4611995631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671762, encodeId=6f8316e176262, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关, objectType=article, longId=115382, objectId=0ecd115382c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecd115382c0, replyNumber=0, likeNumber=67, createdTime=2018-02-02, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecd115382c0, moduleTitle=Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ecd115382c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671759, encodeId=894516e175993, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=PLoS ONE：乙肝患者中，男性患严重肝脏疾病的风险高于女性！, objectType=article, longId=106853, objectId=aa7f106853a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7f106853a8, replyNumber=0, likeNumber=66, createdTime=2018-03-21, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7f106853a8, moduleTitle=PLoS ONE：乙肝患者中，男性患严重肝脏疾病的风险高于女性！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aa7f106853a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671755, encodeId=0a1616e17551b, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！, objectType=article, longId=98304, objectId=bb41983049e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb41983049e, replyNumber=0, likeNumber=78, createdTime=2017-11-06, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb41983049e, moduleTitle=PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bb41983049e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671752, encodeId=3f9c16e175257, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Lancet Gastroen Heptaol：核苷酸类似物治疗的乙肝患者该不该添加干扰素治疗？, objectType=article, longId=87927, objectId=1d168e92719, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d168e92719, replyNumber=0, likeNumber=86, createdTime=2017-09-29, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d168e92719, moduleTitle=Lancet Gastroen Heptaol：核苷酸类似物治疗的乙肝患者该不该添加干扰素治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d168e92719)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671753, encodeId=fd8616e175331, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=慢乙肝患者停药将有检验依据, objectType=article, longId=92496, objectId=af4392496c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4392496c3, replyNumber=0, likeNumber=75, createdTime=2017-06-22, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4392496c3, moduleTitle=慢乙肝患者停药将有检验依据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=af4392496c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671757, encodeId=f31f16e17571e, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Am J Gastroenterol：纤维化扫描（Fibroscan）在评估慢性乙肝患者晚期纤维化后长期抗病毒治疗效果中的作用, objectType=article, longId=102128, objectId=29cf10212805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29cf10212805, replyNumber=0, likeNumber=72, createdTime=2017-08-04, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29cf10212805, moduleTitle=Am J Gastroenterol：纤维化扫描（Fibroscan）在评估慢性乙肝患者晚期纤维化后长期抗病毒治疗效果中的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=29cf10212805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671756, encodeId=5d0216e17569b, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Hepatology：间充质基质细胞可提高乙肝患者生存率！, objectType=article, longId=100143, objectId=03cd10014393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03cd10014393, replyNumber=0, likeNumber=69, createdTime=2018-01-21, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03cd10014393, moduleTitle=Hepatology：间充质基质细胞可提高乙肝患者生存率！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=03cd10014393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671761, encodeId=b9bc16e1761e2, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Liver Int：高尔基体蛋白73联合肝硬度检测可准确评估慢性乙肝患者的显著性肝纤维化, objectType=article, longId=110706, objectId=8829110e06ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8829110e06ac, replyNumber=0, likeNumber=73, createdTime=2018-04-04, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8829110e06ac, moduleTitle=Liver Int：高尔基体蛋白73联合肝硬度检测可准确评估慢性乙肝患者的显著性肝纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8829110e06ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671760, encodeId=f0bf16e17603b, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, objectType=article, longId=106882, objectId=61e910688226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61e910688226, replyNumber=0, likeNumber=90, createdTime=2017-10-04, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61e910688226, moduleTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61e910688226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671754, encodeId=a27f16e1754cf, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=乙肝患者生孩子需要注意这些细节, objectType=article, longId=93107, objectId=545f9310e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=545f9310e6c, replyNumber=0, likeNumber=84, createdTime=2017-11-17, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=545f9310e6c, moduleTitle=乙肝患者生孩子需要注意这些细节, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=545f9310e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671751, encodeId=735416e175118, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, objectType=article, longId=70400, objectId=e9bae04003f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9bae04003f, replyNumber=0, likeNumber=95, createdTime=2016-09-09, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9bae04003f, moduleTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e9bae04003f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671750, encodeId=0c5c16e17500a, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Am J Gastroenterol：他汀类药物可降低乙肝患者肝硬化风险, objectType=article, longId=68655, objectId=87036865582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87036865582, replyNumber=0, likeNumber=94, createdTime=2017-02-26, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87036865582, moduleTitle=Am J Gastroenterol：他汀类药物可降低乙肝患者肝硬化风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=87036865582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671749, encodeId=bae216e17492a, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大, objectType=article, longId=44856, objectId=c75044856f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75044856f3, replyNumber=0, likeNumber=66, createdTime=2015-04-30, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75044856f3, moduleTitle=Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c75044856f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1671748, encodeId=9a7516e174837, content=<a href='/topic/show?id=0bcc2342943' target=_blank style='color:#2F92EE;'>#乙肝患者#</a>, objectTitle=J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？, objectType=article, longId=44855, objectId=c021448557a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c021448557a, replyNumber=0, likeNumber=85, createdTime=2015-03-08, rootId=0, userName=sjzlzc016, userId=fc1826842253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c021448557a, moduleTitle=J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c021448557a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乙肝患者

2020-05-29

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

BMC Med：乙肝患者更易肾损伤

2018-09-21

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：抗血小板治疗会降低慢性乙肝患者HCC风险吗？

2018-01-03

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：多重耐药乙肝患者：替诺福韦单药治疗可行吗？

2018-06-04

柳叶一刀 (审核中...)

前往app查看评论内容

#乙肝患者#

乙肝患者服药后身高缩了8厘米，法院判决医院承担30%责任

2018-11-02

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险

2018-02-03

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果

2018-07-31

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关

2018-02-02

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

PLoS ONE：乙肝患者中，男性患严重肝脏疾病的风险高于女性！

2018-03-21

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！

2017-11-06

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Lancet Gastroen Heptaol：核苷酸类似物治疗的乙肝患者该不该添加干扰素治疗？

2017-09-29

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

慢乙肝患者停药将有检验依据

2017-06-22

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Am J Gastroenterol：纤维化扫描（Fibroscan）在评估慢性乙肝患者晚期纤维化后长期抗病毒治疗效果中的作用

2017-08-04

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Hepatology：间充质基质细胞可提高乙肝患者生存率！

2018-01-21

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Liver Int：高尔基体蛋白73联合肝硬度检测可准确评估慢性乙肝患者的显著性肝纤维化

2018-04-04

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究

2017-10-04

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

乙肝患者生孩子需要注意这些细节

2017-11-17

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好

2016-09-09

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Am J Gastroenterol：他汀类药物可降低乙肝患者肝硬化风险

2017-02-26

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大

2015-04-30

sjzlzc016 (审核中...)

前往app查看评论内容

#乙肝患者#

J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？

2015-03-08

科室
- - 订阅+
  - 更多科室
工具
服务